Failure pattern after response to reversible tyrosine kinase inhibitors in advanced non-small cell lung cancer.

e18030 Background: Reversible tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR) significantly increase survival for patients with previously treated advanced non-smal...